Anavex Life Sciences Corp (AVXL)

[crescentmotor]

I suspect he is one of the reasons behind the SP raise together with the analyst to a lesser degree.

In addition, there is only so much blood to wring out of a chicken's neck. The shorts made a killing here over the past three years bringing the stock price down from $31.50 to a low of $3.25. Even the most aggressive long-term shorts should be more than satisfied with those gains and ready to cover their positions. There are no upcoming binary events to serve as a red flag to attract new shorting efforts. In addition, we may be only a couple of months away from a MAA filing in Europe that will start a regulatory clock for possible approval of Blarcamesine for AD. I believe AVXL has survived the storm is moving into quieter waters.